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Premature termination of psychotherapy, often referred to as “dropout”, is a commonly 
occurring phenomenon that can have deleterious effects on both clinical practice and research.  
Unexpected termination can increase wasted “no-show” hours, and it may demoralize therapists 
and reduce their effectiveness (Barrett et al.., 2008; Klein, Stone, Hicks & Pritchard, 2003; 
Sledge, Moras, Hartley & Levine, 1990).  Dropout may also pose unique challenges in a research 
context, as patients who fail to complete study protocols can affect analyses and outcomes, and 
high dropout rates may complicate interpretation of results.  However, to date, dropout has not 
been extensively studied in randomized controlled trials (RCTs) of psychotherapies.  Estimates 
of dropout and data on variables that predict dropout may improve the quality of psychotherapy 
research by informing study design and providing a more appropriate comparison for observed 
dropout rates.  This paper uses meta-analytic techniques to provide an estimate of dropout in one 
common kind of psychotherapy RCT – namely, studies that involve individual treatments for 
depression – and to investigate potential predictors of dropout in this context.   
Psychotherapy Dropout 
Two kinds of studies dominate the existing literature on estimates of psychotherapy 
dropout and predictors of dropout.  The first consists of large-scale epidemiological 
investigations of dropout across all kinds of mental health treatments, which are typically 
assessed using survey methods (see Edlund, Wang, Berglund, Katz, Lin & Kessler, 2002; Olfson 
et al.., 2009; Wang, 2007; Wang, Gilman, Guardino, Christiana, Morselli, Mickelson, et al.., 
2000).  The second consists of smaller-scale studies evaluating patient-level predictors, mostly 
conducted in the context of community mental health clinics or private practice (see Mueller & 
Pekarik, 2000; Oei & Kazmierczak, 1997; Persons, Burns & Perloff, 1988; Rusch et al., 2008).  
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Estimates of the dropout rate in community treatment samples have been reported as ranging 
from 24% to 66% (Bados, Balaguer, & Saldana, 2007).  Some patient characteristics have 
emerged as predictors from this research; however, results have not been consistent, perhaps in 
part due to considerable methodological variability in studies of this kind (Reis & Brown, 1999).   
Defining dropout in a clinical context is a major issue in this domain of research, as 
variation in definitions can dramatically affect estimates of overall rates (see Barrett et al., 2008; 
Reis & Brown, 1999; Wierzbicki & Pekarik, 1993).  For instance, Wierzbicki and Pekarik (1993) 
noted a 12% difference in overall dropout rate based on whether dropout was defined as the 
failure to attend a scheduled session versus basing dropout on therapist judgment.  This issue 
highlights a potentially meaningful difference between clinical practice and psychotherapy 
research.  In clinical practice, defining dropout may be complicated due to ambiguous markers of 
treatment attendance and expected length; by contrast, researchers using RCTs to investigate 
psychotherapeutic interventions often impose structure as part of the study protocol that makes 
identifying dropouts more straightforward.  This may make dropout in a research context 
somewhat different than dropout in community clinical samples, and suggests the possibility that 
dropout estimates might differ between these two settings.   
In the context of psychotherapy RCTs, dropout has the potential to affect more than 
therapist effectiveness and patient care.  Dropouts may unbalance group designs for data 
analyses and reduce power to detect effects.  Conventional methods for dealing with dropout in 
data analyses (e.g., intent-to-treat analyses) may yield distorted results (Lane, 2008) that may be 
difficult to interpret, especially when dropout levels are very high in one treatment arm but not 
others (see, for example, Coffman, Martell, Dimidjian, Gallop & Hollon, 2007).  Yet despite the 
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increasing number of psychotherapy RCTs being conducted, the existing dropout literature is 
absent an extensive investigation of the phenomenon in the context of psychotherapy RCTs.   
Researchers conducting RCTs may have need for information about expected dropout 
rate, and may also benefit from information about any study characteristics that predict changes 
in dropout.  This information may be critical for procurement of grants, recruitment efforts, 
resource management, determining study and group size, and for structuring data analyses and 
estimating power.  In addition, such data may be relevant to researchers with projects already 
underway to know if they are experiencing atypical dropout rates.  However, the existing 
literature on dropout predominantly focuses on community clinical samples and private practice, 
which may not be well suited to comparison to RCTs.  Looking to similar research designs for a 
comparison may yield a wide range of dropout rates.  As such, psychotherapy researchers may 
be without a clear precedent or estimate by which to gauge the likely rate of dropout in a given 
research design.   
An empirically-derived estimate of dropout from psychotherapy research may be useful 
to investigators developing RCTs, and information about study or treatment characteristics that 
predict changes in dropout rate may also help inform research design and give context to 
observed dropout rates.  As psychotherapy research is a heterogeneous field, it may be especially 
important for such data to incorporate a range of study designs, sizes and psychotherapy formats, 
so as to provide a comparison for researchers working with a multitude of protocols.  A study-
level analysis of dropout rates, and of predictors of dropout, may provide researchers with a 
more appropriate and empirically-informed method of considering how dropout is likely to affect 
their own RCTs.   
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In order to facilitate a more straightforward investigation of this issue, I will focus on a 
single diagnosis – major depressive disorder.  This approach preserves the heterogeneity in study 
design that allows for the evaluation of study-level predictors, while removing much of the 
potential for complications arising from disorder-specific differences in treatment format and 
duration.  Evidence of differential dropout rates by primary diagnosis (see Persons, Burns & 
Perloff, 1988; Stark, 1992; Wang, 2007) highlights both the need for further study on this matter, 
and the potential value of focusing on a single disorder for an initial study such as this.  Major 
depressive disorder is an ideal candidate in this regard, as it has been extensively studied in a 
large number of clinical trials.   
As RCTs vary with respect to the conditions being tested (e.g., psychotherapy versus 
medication, psychotherapy versus psychotherapy), evaluating predictors of dropout at the study 
level may prove imprecise with respect to specific features of psychotherapy conditions.  As 
such, data on dropout will be collected at both the treatment-level (that is, a particular arm of a 
psychotherapy RCT), and at study level (that is, overall dropout rate).  Treatment-level analyses 
will be restricted to active psychotherapy interventions.  With this information collected, 
secondary analyses exploring differences in dropout rate as a function of treatment and study 
characteristics can be conducted.   
Study Characteristics as Predictors of Dropout 
Although many variables have been investigated as predictors of dropout, the existing 
literature has failed to identify any robustly consistent predictors.  As such, the following 
variables were selected for this meta-analysis based on both empirical evidence, and their 
potential to be useful and easily measured variables for psychotherapy researchers: treatment 
type, therapist experience/credentials, intervention length, comorbid conditions (separated into 
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Axis I diagnoses, personality disorders, and anxiety disorders), mean age and proportion of 
minority patients of the study sample, socioeconomic status (SES), and effect of intervention on 
depressive symptoms.   
Psychotherapy treatment type may be an especially compelling treatment variable in light 
of the long history of comparative studies in treatment of depression.  In an analysis involving a 
subset of the studies utilized herein, Cuijpers and colleagues (Cuijpers, van Straten, Andersson & 
van Oppen; hereafter, Cuijpers et al., 2008a) reported a slightly higher risk of dropout in studies 
involving cognitive-behavioral therapy, and a slightly lower risk of dropout in those involving 
supportive-expressive therapy; however, the authors noted that the number of samples of each 
therapy included in these analyses were disparate (28 for CBT vs. 5 for SE) and cautioned 
interpreting the finding without considering differences in definition of dropout.  Nonetheless, 
this finding suggests that there may be some useful variability in dropout rates across different 
treatment types.   
A number of studies have found support for the notion that therapist experience reduces 
risk of dropout (for a brief review, see Roth & Fonagy, 2005, p.453), though null findings have 
also been reported (Wampold & Brown, 2005).  Therapist training and credentials have been less 
extensively studied, and the results have also been largely inconsistent to date (for a review, see 
Beutler et al.., 2003; Hamilton, Moore, Crane & Payne, 2010).  With respect to treatment length, 
there is some evidence to suggest that short-term interventions tend to have lower dropout rates 
when contrasted with longer forms of similar interventions (Sledge et al., 1990).  This topic has 
not been studied extensively as a predictor of dropout, perhaps because of its relationship to 
dropout itself in treatment-as-usual clinical settings, where duration may be negotiated between 
client and therapist as opposed to explicitly defined by study parameters. 
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The preponderance of available evidence suggests that younger patients, those with lower 
incomes (associated with low SES) and those from minority groups are more likely to drop out 
(Edlund et al., 2002; Wang et al., 2000) although there are contradictory findings for each of 
these variables (Arnow et al., 2007; Olfson et al., 2009).  There are also empirical reasons to 
suspect that comorbid diagnoses may increase dropout rate dropout.  Olfson et al. (2009) 
reported a trend level prediction of elevated risk of dropout amongst patients with multiple 
psychiatric conditions.  Similarly, Arnow et al. (2007) reported that dropouts were more likely to 
have an anxiety disorder than completers; this may be an especially useful comparison, as 
anxiety and depression commonly co-occur.  In a sample of CT-treated patients, Fournier et al. 
(2008) reported a trend level interaction between treatment assignment and Axis II diagnoses in 
the prediction of dropout, such that people with personality disorders were more likely to drop 
out of cognitive therapy.   
Finally, the relationship between the effect size of an intervention and the dropout rate is 
a complex issue that has not been extensively explored in the existing literature.  Dropout has 
considerable potential to influence observed results from an analytic standpoint, having the 
potential to increase effect sizes in completer analyses and potentially dampen them in intent-to-
treat analyses.  As such, exploring the relationship between dropout and effect of intervention 
will require thoughtful consideration in the context of this meta-analysis. 
Criteria for Inclusion in Meta-Analysis 
Capturing some variability in terms of study characteristics is critical to a comprehensive 
effort to identify study-level predictors of dropout.  However, too much variability may yield 
results that are difficult to interpret, so three restrictions will be added to the criteria for inclusion 
in this meta-analysis in order to aid the ease of interpretation.  Included studies must be 
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investigations of (1) outpatient psychotherapy, involving (2) face-to-face individual treatment 
with (3) patients formally diagnosed with major depressive disorder.  The rationale for each of 
these restrictions is addressed in turn below.   
The exclusion of studies that involve non-outpatient treatment (e.g., in-patient or 
emergency psychiatric care) is predicated upon concerns that this population may have 
meaningful differences in how dropout is defined.  It is possible that such patients may be less 
likely to be lost to follow-up in the same way that a traditional outpatient might be, by virtue of 
being cared for in an in-patient setting.  Studies in which patients are recruited while in-patients 
for later outpatient treatment will be included (e.g., recruiting pregnant mothers in hospital).  
Interventions that are not strictly individual psychotherapy will also be excluded (i.e., group, 
couples, or guided bibliotherapy).  There is some reason to believe that rates may differ across 
these modes of delivery (see, for example, Organista, Munoz & Gonzalez, 1994; Minniti et al., 
2010; Rush & Watkins, 1981).  Furthermore, as with in-patient care, there may be differences in 
definition of dropout in these settings (e.g., patients may be allowed to miss more sessions of 
group than in individual treatments).  As an extension of this, only therapies delivered during 
face-to-face contact will be acceptable.  Finally, studies must have as inclusion criteria a formal, 
primary diagnosis of major depressive disorder or post-partum depression, using DSM or 
comparable criteria through a formal diagnostic process.  As such, analogue populations and 
other depressive disorders (e.g., dysthymia, minor depressive disorder) will be removed.  It is by 
no means absolutely clear that such diagnostic differences will affect dropout rate; however, one 
can easily imagine that they might do so in some non-random way (e.g., less severely ill patients 
may be less motivated to attend).  Although variability in symptom severity would be present to 
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some degree within a formally-diagnosed sample, such effects might occur in a non-random 
fashion for the studies employing analogue or minor depressive populations.   
Definition of Dropout 
As noted above, the definition of dropout is a critical issue for any investigation of 
dropout rates.  For the purpose of this study, the primary dropout variable, treatment-level 
dropout, will refer to the dropout rate of an individual psychotherapy condition that is part of a 
randomized controlled trial.  A given study may thus contribute multiple conditions to this 
analysis
1
.  These analyses are approached from the standpoint of understanding dropout in 
psychotherapy research in terms of unexpected patient loss, among individuals who were 
accepted into the study but who failed to complete it.  For this reason, the earliest point at which 
a patient can be considered a dropout is post-randomization to treatment condition; patients lost 
prior to that point are not considered dropouts because they have not been enrolled in the study 
and classified as a study patient (e.g., patients who attend an assessment but never return to be 
randomized).  Patients who are randomized but refuse their assignment, those who never attend a 
session, and those who stop attending sessions or withdraw consent before the end of the 
treatment period are considered dropouts.  The second dropout variable is based on overall 
dropout, which is the global dropout rate across all conditions in particular study.  Although this 
does not speak to the primary question of interest, it may provide useful data for comparison 
purposes and also to provide an estimate of overall dropout rate in RCTs involving treatments for 
depression.  Overall dropout rates were only collected from studies that were capable of being 
included in the treatment-level analysis; that is, studies that did not report dropout by condition 
were not included in this meta-analysis.   
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In light of variability in treatment duration, information about dropout was only collected 
for the initial or acute phase of treatment in multi-stage studies.  Additionally, administrative 
removals of study patients and instances of data loss were not treated as dropouts.  The rationale 
for their exclusion is that these rates are often reported separately, and often result from failures 
of the inclusion procedures or issues related to concurrent treatment.   
 
Methods 
In lieu of a primary literature search, this study utilizes a comprehensive database of 
RCTs for depression as a starting point for determining study inclusion.  This database is 
available for public use as part of an ongoing effort to provide a comprehensive collection of 
articles for researchers interested in conducting meta-analyses; a description of the efforts to 
develop the database was offered by Cuijpers, van Straten, Warmerdam, and Andersson (2008b), 
and additional information can be found on the website itself (www.psychotherapyrcts.org).    
As described by Cuijpers et al.(2008b), studies were identified in the following way: a 
comprehensive literature search was conducted, identifying articles from 1966 to May 2007 
resulting in 6947 abstracts from PubMed, PsycINFO, EMBASE and the Cochrane Central 
Register of Controlled trials, based on terms indicative of psychological treatment and 
depression.  Studies were also selected from primary meta-analyses of depression and from 
published dissertations.  Treatments were defined as interventions where verbal communication 
between client and therapist was a core feature (allowing for the inclusion of multiple different 
modalities, including guided bibliotherapy and telephone-based interventions).  Studies 
involving non-adult samples were removed, as were studies where the psychotherapeutic 
intervention could not be identified from other aspects of standard care.  Studies in which an 
effect size could not be established were also removed from the database.  As of July 2010, the 
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psychotherapyrcts.org database had identified 243 articles involving a randomized controlled 
trial of one or more psychotherapy in the treatment of depression.  A comprehensive list of these 
articles is available on their website, alongside a database of study characteristics compiled by 
the authors of the website (viz., Cuijpers et al., 2008b).  Figure 1 summarizes the steps for 
generating the dataset in flowchart format. 
Basic descriptive information provided on the website lead to the removal of 130 articles 
for failure to include a formal diagnostic test of major depression (76 articles failed this criterion) 
and/or for not involving an individual, outpatient psychotherapy (92 articles failed this criterion).  
Some studies failed to meet both criteria.  Thus, a total of 113 articles were accepted for a more 
thorough review.  An additional 67 articles were removed from the dataset for a number of 
reasons (outlined in Appendix 1), most commonly for providing insufficient information on 
dropout or for depression diagnosis issues (e.g., primary dysthymia diagnosis).  One study was 
removed because it was based on the same sample as another study that had been included.  
Thus, the total number of separate studies included in the meta-analysis was 46.  From this group 
of studies, a total of 69 individual psychotherapy conditions were acceptable for use in the 
primary treatment-level dropout analyses. 
Primary Data Collection  
The RCT database provides information about date of publication, target population, type 
of comparison (e.g., psychotherapy versus pharmacotherapy, etc.) and type of psychotherapy, 
divided into 7 categories (per Cuijpers et al., 2008b): (a) cognitive-behavioral, (b) problem-
solving, (c) interpersonal, (d) non-directive / supportive therapy, (e) behavioral activation, (f) 
psychodynamic, and (g) other.  Target population is also provided, classified as: adults, older 
adults, women with post-partum depression (PPD), patients with general medical conditions, and 
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“other”.  Dropout rates and all other potential predictor variables were collected during the 
review process.  Additional information was recorded concerning the specificity of the variables 
in question – that is, whether or not estimates were provided by condition, across the entire 
study, or only for completers.  Estimates not provided by condition were only retained if the 
variables in question were identified as not varying meaningfully between conditions, or between 
completers and dropouts.  Primary analyses were conducted using all available data, unless 
otherwise discussed.   
Table 1 indicates the availability of data on each of the potential predictors in the 
treatment-level analysis, along with mean and weighted mean values where applicable.  Some of 
the variables were collected in multiple formats.  For instance, information about therapist 
credentials was collected in two ways: a categorical variable reflecting the most common degree 
of therapists in the study, and as a continuous estimate of mean years of experience.  Similarly, 
information about treatment duration was collected in terms of both intended and observed 
duration, and in terms of weeks and number of sessions, where available.  Notably, 
socioeconomic status was not included in Table 1 because the information was provided in less 
than a quarter of cases (16 of 69), and estimates were of sufficient variety and imprecision that 
creating an overall index proved impossible.  It also bears noting that most of the data on 
comorbid conditions took the form of exclusion criteria; as such, the mean values of these 
variables may appear low, as the most common value was zero when exclusion criteria were in 
place.  Information about these conditions was also generally less commonly available.   
Information about the effect of intervention was collected by recording pre-post scores on 
the two most commonly utilized measures of depressive symptoms: the Beck Depression 
Inventory, versions I (Beck, Ward, Mendelson, Mock & Erbaugh, 1961) and II (Beck, Steer & 
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Brown, 1996), and the Hamilton Rating Scale for Depression (Hamilton, 1960).  Cohen’s d 
effect sizes were calculated for these variables.  Condition-level mean values that were explicitly 
identified as coming from an intent-to-treat population (that is, from the entire sample including 
dropouts) were separated from those identified as completers-only, or where no information was 
provided.  In cases where no information was provided, a conservative approach was adopted in 
performing analyses, such that effect size estimates were calculated assuming these were 
completer analyses (viz., using pooled standard deviations for calculations based on number of 
completers).   
Analytic Strategy 
Both treatment- and study-level dropout rates were transformed using the variance 
stabilizing Freeman-Tukey double arcsine transformation (Freeman & Tukey, 1950), which 
weights the proportions very slightly towards 50% and thus allows for the inclusion of trials with 
zero proportions (for an explanation, see Lipsey & Wilson, 2001).  Heterogeneity in the sample 
was evaluated using Cochran’s Q-statistic (Cochran, 1954) and the related I2 statistic (Higgins, 
Thompson, Deeks & Altman, 2003), which describes the percentage of variation across studies 
that is the result of true heterogeneity as opposed to chance.  I
2
 is easily interpreted, with values 
of 25%, 50% and 75% corresponding to low, moderate and high heterogeneity.  When 
heterogeneity (between-study variability) is high, analyses should be conducted in a random-
effects model (Higgins et al., 2003).  A lengthy discussion of this issue is not appropriate, and 
can be found elsewhere (see Hedges & Vevea, 1998; Schulze, 2004); however, a simple version 
of the random versus fixed effects issue is that fixed effects models assume that all studies 
included in the meta-analysis are drawn from the same theoretical population.  Conversely, in 
random effects models, study weights are calculated as the sum of the weight used in a fixed 
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effects models plus the between-study variability.  In practice, these weights are typically very 
similar to those produced in fixed effects models, but they are better able to reflect between-
study variation and provide more equal weighting.   
Primary analyses consisted of providing an overall estimate of dropout rate across all 
studies, along with estimates for each of several relevant, categorical subgroups (where 
statistically appropriate based on group size).  Meta-regression analyses utilized mixed 
regression models to predict the transformed dropout rate using the variables noted above (akin 
to models reported by Cuijpers, van Straten, Warmerdam, & Smits, 2008c).  All primary and 
secondary analyses were performed using SAS 9.2, based on guidelines provided by Arthur, 
Bennett & Huffcutt (2001).  Analyses of heterogeneity were first performed in Excel per 
instructions provided by StatsDirect (2009), and subsequently confirmed in SAS.  Finally, a 
funnel plot was constructed to address the possibility of a “file drawer” problem - the tendency in 
research literature towards a positive publication bias.  While such an effect has not been 
explicitly suggested with respect to dropout rate, it is plausible that studies with extremely high 
rates may not be published.  Additionally, a previous study using the same initial collection of 
articles reported some indication of a bias with respect to treatment effect size (Cuijpers, Smit, 
Bohlmeijer, Hollon & Andersson, 2010).  This plot was constructed per guidelines suggested by 
Light & Pillemer (1984; see also, Egger, Smith, Schneider & Minder, 1997).   
 
Results 
The final collection of articles included 46 separate publications (19% of the 
psychotherapyrcts.org database), with a total of 2802 patients and 69 treatment conditions 
represented (see Appendix 2 for a full listing of studies and conditions)
2
.  The mean number of 
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conditions per article represented in these analyses was 1.5, with a range of 1 to 3.  Four authors 
contributed more than one article as the primary author.  The final collection included studies 
published between 1976 and 2009, and 60% of the articles were published in 2000 or later.  The 
majority of articles were American in origin (54%), with the next largest number of contributions 
originating from the UK (19%).  With respect to other basic characteristics of these studies, the 
majority involved general adult outpatient clientele (65%).  The most commonly examined 
therapy was CBT, which was evaluated in 61% of the studies.  Interventions examined ranged 
from 6 to 30 sessions in duration, with a modal intervention length of 16 sessions.  Overall study 
sizes ranged from 20 to 681 (mean = 112.1, SD = 114).  With respect to comparisons being 
tested in the studies, the most frequently occurring kinds were comparisons of an active therapy 
versus a control (41%), or anti-depressant medication (ADM) versus an active therapy (40%).  
Comparisons between two active psychotherapies were only reported in about a quarter of the 
studies included in this sample.  These categories are not mutually exclusive; that is, a study 
could be classified as involving an active therapy versus control and also a comparison between 
two psychotherapies if it satisfies both criteria (i.e., two psychotherapy arms versus waitlist).  
Concerning implementation, slightly over a third of these studies (36%) included some reference 
to fidelity checking, such as ratings of therapy process and re-training or removal of non-
adherent therapists.   
The 69 individual treatments conditions ranged in size from 10 to 228 subjects (mean = 
40.6, SD = 39.9).  Once again, the most common psychotherapy format was CBT (52% of 
conditions).  Twenty percent of the included conditions were combined psychotherapy and 
pharmacotherapy, and only 3 % involved a pill placebo in conjunction with therapy.  Most 
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treatments were delivered by clinical psychologists; 38% of studies involved only psychologists, 
and an additional 20% involved a mixed group of psychologists and other professionals.   
Heterogeneity Analyses 
All heterogeneity analyses were conducted using formulae specifically applicable to 
Freeman-Tukey double arcsine transformed data.  (In the interest of interpretability and 
convenience, all statistical reporting and figures utilize actual proportion estimates, as the 
transformed data are less clearly interpretable).  For the treatment-level analysis, the observed 
value of the Q-statistic was 242.42.  The Q-statistic is compared relative to a critical chi-square 
value which, for 68 degrees of freedom and α = .05, is 88.25.  As the observed value is 
considerably greater than the critical value, this indicates there is significant heterogeneity in this 
sample.  The I
2
 value for this sample corresponds to 71.9%, with a 95% confidence interval of 
64.1 to 78.1, calculated using the method suggested by Higgins and Thompson (2002).  
Interpreted in line with the anchors suggested by Higgins and colleagues (2003), this is a high 
level of variability, with approximately 72% of the total variability in dropout estimates being 
attributable to true heterogeneity between studies as opposed to sampling error.  For the overall 
dropout rate, the observed value of the Q statistic was 227.5, which is greater than the critical 
value of 61.66 (for 45 degrees of freedom and α = .05).  Accordingly, the overall dropout 
estimate is also considered significantly heterogeneous.  The I
2
 value for this sample corresponds 
to 80.2%, a high level of variability, with a 95% confidence interval of 72.3 to 85.9.  These 
results unambiguously support the use of random effects models in all subsequent analyses.   
As the results of these analyses show, the heterogeneity observed in the treatment-level 
sample is quite high.  As therapy type may be the most prominent distinction between treatments 
in this meta-analysis, heterogeneity analyses were also conducted for each subgroup.  Results of 
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these analyses are reported on the right side of Table 2.  Nearly all therapy types evidenced 
significant heterogeneity with respect to predicted dropout rate; the sole exceptions were 
behavioral therapies (5 conditions) and those classified as “other” (3 conditions).  A Qbetween 
score, representing the difference between the overall Q-statistic and the sum of the individual 
therapy type Q-statistics, tests the hypothesis that the grouping variable (viz., therapy type) 
accounts for significant variability in dropout estimates.  The Qbetween estimate is 32.8 and is 
larger than the critical value (Qcrit =12.6); thus, there are meaningful differences in the 
heterogeneity of these subgroups.   
Estimates of Mean Dropout Rate 
In meta-analysis, the mean dropout rate is calculated as a pooled proportion estimate, 
weighted by study size.  In a fixed-effects model, this corresponds to the squared product of the 
sine of the standardized dropout rate.  The random-effects model incorporates between-study 
variance into this estimate.  For the treatment-level analyses, the pooled proportion estimate for 
the random effects model is .1696.  By way of comparison, the fixed-effects estimate is slightly 
higher at .1879, suggesting a non-trivial difference in estimates based on model specifications.  
Thus, the best estimate of dropout rate across the entire sample is about 17 percent.  Figure 2 
shows a forest plot of the treatment-level dropout rates, which are not transformed in this figure 
in the interest of interpretability.  For the overall dropout rate, the pooled proportion effect for 
the random effects model is .1929, with the comparable fixed-effects estimate slightly higher at 
.2089.  The best estimate of overall dropout rate, across all 46 studies included in the sample was 
about 19%, slightly higher than the mean dropout rate for psychotherapy conditions.  Figure 3 
shows a forest plot of the overall dropout rate, with the vertical line representing this average 
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value.  Table 2 provides estimates of mean dropout rate for each therapy type; these estimates 
range from 14.8% (cognitive-behavioral) to 24.8% (“other” therapies).   
Rater Reliability Estimates 
A subset of the sample (11 studies, including 17 conditions) was randomly selected for 
the purpose of conducting reliability analyses on variables collected as a part of this study.  An 
advanced undergraduate student was trained in the coding system, provided with a sample study, 
and then asked to make ratings based on this information.  Intra-class correlations (ICCs) were 
conducted for continuous variables (McGraw & Wong, 1996), and are reported in Table 1.  The 
ICC estimates generally suggested good reliability, with values of .89 or greater for all but one 
variable.  The ICC for comorbid substance abuse was .13, likely attributable to considerable 
discordance in a single study and a small number of comparisons.  Nevertheless, this variable 
was removed from subsequent analyses due to concerns about reliability.  Encouragingly, ICC 
estimates for condition-level dropout and study-level dropout were .93 and .97 respectively, 
suggesting that the primary predicted variable was reliably identified in the subset of studies 
rated here.   
 The only categorical predictor variable included in the dataset was therapist credentials.  
Visual inspection of the confirmatory ratings suggested very low reliability, due in part to 
differences in encoding studies involving therapists from multiple categories (e.g., studies in 
which most therapists were Ph.D. psychologists, but one therapist was a nurse or social worker).  
As a consequence, this variable was removed from the dataset, and from further analyses due to 
concerns about reliability.    
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Meta-Regression Analyses 
Table 3 shows the results of the meta-regression analyses.  As per the results of the 
heterogeneity analyses, all meta-regression analyses were conducted with between-studies 
variance modeled as a random effect.  However, because not all variables were available for all 
conditions, most analyses involve slightly different datasets.  There were no statistically 
significant predictors of treatment-level dropout.  Whereas the Qbetween analyses suggest 
meaningful differences in the level of heterogeneity observed by subgroup, treatment type was 
not a significant predictor of dropout, and none of the planned contrasts between the groups were 
significant.  However, intended duration in weeks appeared to predict dropout at the level of a 
non-significant trend (t(57) = 1.73, p = .09).  A median split was performed on this data, 
resulting in 33 treatments classified as “short” duration, and 26 as “longer” duration.  Conducting 
estimates of mean dropout rate, studies with shorter duration had an estimated 14% dropout, 
whereas those with longer duration had an estimated 20% dropout; however, when tested as a 
contrast, this difference was not statistically significant (p =.176).  Additional analyses were 
conducted while controlling for intended duration in weeks; they are not reported here in the 
interest of space.  As in the primary analyses, none of the aforementioned variables significantly 
predicted dropout in this model.  Percentage of comorbid personality disorders also appeared to 
predict dropout rate at the level of a trend (t(13) = 1.91, p = .08).  However, as reported in Table 
1 and noted above, data on this variable was infrequently provided, and often only in the form of 
exclusion criteria.  As such, the result should be interpreted with caution.   
In the interest of evaluating potential predictors of overall dropout rate, a second meta-
regression was conducted using some of the study-level variables provided in the RCT database 
(namely, target group, publication year, type of comparison, and type of therapy).  In these 
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analyses, the therapy type variable refers to whether or not a given therapy was used in one or 
more conditions in the study, unlike the treatment-level analyses, which were separated and 
classified on the basis of a single therapy type.  Results are reported in Table 4.  As in the 
treatment-level analyses, none of these variables predicted overall dropout rate.   
Publication Bias 
A funnel plot was constructed to evaluate the possibility of publication bias related to 
dropout rate (see Figure 4).  The vertical axis measures standard error of the dropout estimate, 
with the dropout rate on the horizontal axis.  In contrast to typical funnel plots, data-points closer 
to the left side of the horizontal axis likely represent the best outcomes, as they depict lower 
dropout rates.  The funnel plot appears somewhat symmetrical, although three studies separate 
from the general tendency toward symmetry by reporting lower dropout rates in a larger study.  
Also, there are conspicuously few small studies that report high dropout rates (that is, studies low 
on the vertical axis but high on the horizontal axis).  A plausible interpretation is that there may 
be a tendency for small studies to report lower dropout rates, suggesting the possibility that small 
studies with higher dropout rates may be subject to a “file drawer” effect.   
 
Discussion 
 The primary aim of this meta-analysis was to provide an estimate of dropout rates in 
psychotherapy treatment conditions in RCTs for major depression.  Those estimates were 17% 
for individual conditions, and 19% for overall dropout rates in trials of this kind, with both 
populations evidencing high levels of heterogeneity in the estimate.  Secondary aims of the study 
were to evaluate potential predictors of dropout from a collection of study- and treatment-level 
variables.  Despite notable heterogeneity in the dropout estimates (implying true variability in the 
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dropout rate and thus the possibility of detecting meaningful variation), there were no significant 
predictors of dropout rate in either the treatment- or the study-level analysis.  Treatment duration 
predicted dropout at the rate of a non-significant trend, but a dichotomous split of this variable 
did not yield significant differences.  Heterogeneity estimates were significantly predicted by 
therapy type in the treatment-level, but this may have been due to disproportionate representation 
across all 7 categories.  Almost all therapy subgroups evidenced significant estimates of 
heterogeneity, with the two exceptions (behavioral and “other” therapies) being comprised of a 
small number of conditions, and in one case consisting of multiple treatments from the same 
study in the group.   
Considering the observed mean dropout rates in the context of the existing literature 
highlights the utility of deriving more precise estimates of dropout relative to particular 
conditions (e.g., in psychotherapy research; for a particular diagnosis; in a community sample, 
etc.).  For instance, a researcher conducting a small RCT involving cognitive therapy for 
depression might look to the existing RCT literature and observe that dropout from CT 
conditions ranges from zero to 37 percent, as in our sample.  In searching for an average 
estimate, the researcher might find dramatically different rates reported in dropout literature in 
clinical practice using CT  (40 - 50%; Persons et al., 1993; Trepka, 1986) versus large-scale 
community samples with variable diagnoses and treatment approaches (16 – 20%; Edlund et al., 
2002; Olfson et al., 2009).  It is likely that an argument could be made for using any of these 
estimates; however, a more precise and applicable estimate would strengthen the researcher’s 
ability to use it in an informative way in designing the study.  With additional efforts to refine 
and expand this process to incorporate a broader range of treatment types and diagnoses, there is 
potential for a superior method of evaluating one’s dropout rate to emerge.   
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With respect to the process of identifying dropout rates, it bears noting that the majority 
of studies that were excluded from the sample were removed in the interest of reducing certain 
sources of variability (e.g., disallowing group treatments, etc.).  As such, the true proportion of 
all depression RCTs that provided dropout rates cannot be easily ascertained from the estimates 
provided herein.  However, from the studies that were reviewed more extensively for dropout 
information, a surprising number were removed on the grounds of failure to report dropout rate 
by condition in an unambiguous fashion (see Appendix 1).  Although directives such as the 
CONSORT statement (Moher et al., 2010) may be expected to improve the quality of reporting 
in journals that implement these standards, there is a pressing need to increase transparency 
about dropout rates in RCTs, regardless of the journal of publication.  The estimates derived in 
this study only represent a fraction of the available literature, and otherwise strong studies that 
fail to report on dropout in a straightforward fashion do a disservice to the field.   
There are multiple ways of interpreting the failure to detect significant predictors.  It is 
plausible that they reflect a true non-relation between the selected variables and risk of dropout.  
If true, this would suggest either a problem identifying relevant predictor variables or an issue 
with the type of analysis being performed.  The former outcome is certainly possible, as the 
variables were selected largely on the basis of their role as predictors in large-scale 
epidemiological investigations of dropout, a literature that is not without contradictory findings.  
Similarly, it may be that dropout rates in psychotherapy treatments of RCTs for depression are 
better predicted by intermediate variables that were not included, or are not amenable to 
condition- or study-level investigations.  Higgins and Thompson (2004) commented that in meta-
analyses with very high heterogeneity with numerous predictor variables, spurious predictive 
findings are likely to be reported due to the nature of the analyses.  Although no significant 
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predictors were identified in this study, the potential for misleading results in future analyses 
should be addressed by thoughtful, a priori selection of predictor variables. 
The analyses related to therapy type warrant additional consideration.  Although there 
was no evidence of differences in dropout rates between therapy types – a finding that may be in 
part due to small numbers of treatments for most therapies – the differences in heterogeneity give 
rise to the potential for differential predictors (or predictive abilities) by therapy.  The lack of 
differences between therapy types contrasts with findings reported by Cuijpers and colleagues 
(2008a).  Using overall dropout rates in a study involving only psychotherapy versus 
psychotherapy comparisons (with a database that included many studies in common with the 
present study), they reported an elevated risk of dropout in studies involving cognitive therapy, 
and a reduced risk in problem-solving therapies.  The authors noted that the disproportionate 
representation of these therapies might be a reason for caution in interpreting their findings.  As 
the same imbalance is true of the present study, with cognitive therapy being better represented 
in the sample than other therapies, this non-finding should also be interpreted with caution.   
An additional possibility is suggested by the finding that therapy types differ with respect 
to heterogeneity of dropout estimates.  Although there was no evidence of differences in dropout 
rates between therapy types – a finding that may be in part due to small numbers of treatments 
for most therapies – the differences in heterogeneity give rise to the potential for differential 
predictors (or predictive abilities) by therapy.  That is, heterogeneity in “true” estimate 
variability across therapy types suggests at least the possibility that different predictors may be at 
play.  Unfortunately, the small numbers of examples of most therapy types do not allow for an 
adequate evaluation of this question, as moderation analyses using therapy type as a moderator 
would likely be under-powered, especially since almost none of the predictor variables were 
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available for every condition (Hedges & Pigott, 2003).  Conducting moderator analyses in low 
power conditions may yield results that are difficult to interpret, especially in the absence of 
significant findings.  Future efforts to extend this research area to additional RCT variants may 
open up the possibility of moderator analyses that can adequately test hypotheses.  
Considering the results of the funnel plot and the issue of publication bias, there may be a 
relationship between study size and dropout rate in this collection of studies.  This was an 
exploratory analyses conducted without a clear precedent to suspect such an effect; however, the 
observed result may make some intuitive sense in light of some known properties of published 
trials.  The rationale for investigating publication bias is that studies with significant findings 
may be more likely to be published, and those without significant findings more likely to be 
relegated to file drawers.  Additionally, RCTs conducted with larger samples may be more likely 
to be published than those conducted in smaller samples (perhaps because they are grant-
supported or considered more precise due to better power to detect effects).  When dropout rates 
are high, they may complicate interpretation of results, perhaps especially so in last-observation-
carried-forward analyses, where they may reduce the magnitude of observed effects (Lane, 
2008).  Small studies may be particularly susceptible to these effects, and especially sensitive to 
aberrant dropout rates.  As such, high dropout rates in small studies may be conspicuous in their 
own right, and may interfere with findings of interest, compounding the likelihood that the study 
will not be submitted or accepted for publication.   
Limitations 
The estimates derived in this study may prove informative to those interested in dropout 
in the context of psychotherapy research, and, more specifically, in those types of studies to 
which these analyses were restricted.  In the interest of constructing a straightforward 
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comparison, several types of studies were removed from consideration, and as such these results 
may not be easily generalized to studies involving those variables.  Additional efforts to 
construct larger databases will be necessary to improve generalizability.   
A critical limitation of this study is that, while one can informally compare estimates of 
dropout derived from epidemiological designs or clinical contexts to the results derived in this 
paper, a formal comparison has not been conducted.  Additionally, as the estimates of overall 
dropout rate were only obtained from studies with at least one viable psychotherapy condition, it 
is possible that the observed study-level dropout estimate in this sample differs from one 
constructed using all available studies.  However, there is no strong reason to suspect such a 
difference, at least with respect to studies that would meet other inclusion criteria for this study. 
Finally, efforts to evaluate reliability of ratings suggest that while most variables were 
reliably identified, there are still domains in which inter-rater agreement could be improved.  
Future efforts in this dataset and others will incorporate additional ratings for more precise 
estimates, also opening up the potential for consensus ratings, which may improve reliability in 
difficult categorical variables such as therapist experience. 
Conclusions  
The phenomenon of dropout is of considerable interest to both clinicians and researchers 
alike, but the existing literature on the topic may be suboptimal for researchers hoping to 
anticipate dropout rates when designing psychotherapy research studies, or interpret those 
observed in their own RCTs.  This meta-analysis provides an estimate of dropout for a small 
piece of the RCT literature: individual outpatient psychotherapies for major depression.  The 
estimates derived in this study may help researchers conducting RCTs in this field make 
informed decisions with respect to their anticipated dropout rates.   
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Footnotes 
 
1. There is some controversy as to whether or not it is appropriate to include estimates from 
samples within the same study in a meta-analysis and treat them as independent of one another; 
however, Schulze (2004) has argued that inclusion of groups from the same study is likely no 
worse than including multiple studies from the same research group, which are also likely to 
share common sources of variance.  As such, for the purposes of this project, multiple conditions 
within a given study were included in the analyses, so long as participants were ineligible from 
participating in multiple conditions (i.e., participants from one condition cannot have participated 
in the other condition).  
 
2. The 46 articles used in the final meta-analysis are marked with an asterisk in the References 
for ease of identification.  Note that articles were labeled and identified by first author based on 
the version of the database available at time of downloading.  Subsequent revisions to that list 
(due to updated information on later publications) resulted in a name change of one primary 
author: the paper cited in the meta-analysis as “Conradi, 2006” appears in the reference section 
as “Smit et al, 2006”.  In order to maintain connections with the primary database, the original 
name has been retained. Original database citations are also given in Appendix 1 and 2.  
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Table 1. Mean values and availability of treatment- and study-level predictor variables, with 
intra-class correlations (ICCs).  
 
                            Weighted 
     Ncond (%) Mean  Mean  ICC 
 
Mean Age    65 (94) 44.4  42.5  1.00 
% Female Patients   69 (100) 73.0  70.7  1.00 
Therapist Experience (years)  25 (36) 8.5  9.2  1.00 
Duration 
 Sessions Intended  55 (80) 16.4  16.7    .89  
 Weeks Intended  59 (86) 13.9  15.2  1.00 
 Sessions Observed  21 (30) 11.6  12.6  1.00 
% Minority Patients   38 (55) 14.3  13.2  1.00 
Comorbid Substance Use  37 (52) 3.8  3.5    .13 
Comorbid Axis II   15 (22) 31.7  45.4  1.00 
Comorbid Axis I   11 (16) 34.9  43.1  1.00 
Comorbid anxiety disorder  10 (14) 42.5  34.4  1.00 
Pre-post BDI d effect size 
 Any version   37 (54) .28  .27  1.00 
 Confirmed ITT  23 (33) .31  .29 
Pre-post HRSD d effect size 
 Any version   45 (65) .46  .38   .99 
 Confirmed ITT  30 (43) .38  .34 
 
Ncond refers to the number of conditions for which an estimate the corresponding variable  was 
available. Mean values not given for categorical variables. ICC values for BDI and HRSD reflect 
average agreement across pre- and post- scores.  Comorbid substance use was removed from 
further analyses due to poor reliability. 
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Table 2. Heterogeneity statistics and dropout estimates for treatment-level analyses.  
 
Condition   Ncond  Nsubj  Estimate Q  I
2
 
 
All treatments   69  8506  .1879 (F) 242.4*  71.9 
        .1696(R) 
 
   Cognitive   36  3251  .1474 (F) 77.2*  54.7 
 .1481 (R) 
 
   Interpersonal  8  1296  .1862(F) 56.7*  87.7 
        .1674(R) 
 
   Problem-solving  6  593  .1811(F) 18.1*  72.3 
        .1606(R)  
 
   Supportive   3  242  .1325(F) 6.6*  69.5 
        .1348(R) 
 
   Behavioral   4  532  .1658(F) 7.3  59.1 
        .1909(R) 
 
   Dynamic   9  1202  .2396(F) 40.2*  80.1 
        .2288(R) 
 
   Other   3  1390  .2479(F) 3.5  43.6 
        .2446(R) 
 
 
Ncond = total number of individual treatment conditions represented in the primary analyses  
Nsubj  = total number of subjects in the relevant treatment conditions 
Estimate = estimated dropout rate, with (F) and (R) denoting fixed and random effects 
calculations used in deriving estimates. When heterogeneity is significant, random effects 
models are considered the most appropriate estimates.  
* p < .05 
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Table 3. Meta-regression results predicting treatment-level dropout. 
 
Predictor           Estimate SE df   t / F   p  
 
Therapy Type*   - - 62   .59 .73 
Population*    - - 64   .68 .61 
Mean Age     -.002 .004 63 -.48 .63 
% Female Patients   .343 .311 67 1.11 .27 
Therapist Experience  
Years    -.007 .015 23 -.47 .64 
Duration   . 
Sessions Intended  .004 .013 53   .27 .79 
Weeks Intended  .020 .012 57 1.73 .09 
Sessions Observed  .5975 1.03 13   .58 .58 
% Minority Patients   -.006 .594 36   .09 .93 
Comorbid Axis II   -.798 .418 13 1.91 .08 
Comorbid Axis I     .515 .524  9   .98 .35 
Comorbid anxiety disorder   -.002 .005 8 -.31 .77 
Pre-post BDI d effect size 
 Any version   -.283 .393 35 -.72 .48 
 Confirmed ITT  -.249 .418 21 -.59 .56 
Pre-post HRSD d effect size 
 Any version   -.279 .216 43 -.83 .41 
 Confirmed ITT  -211 .276 28 -.77 .45 
Estimates are of unstandardized regression coefficients, with corresponding standard error (SE) 
values. All tests involved random effects models. Results involving categorical variables 
(identified with a *) are given as F statistics, and estimates of regression coefficients are not 
reported.  
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Table 4. Meta-regression results predicting overall dropout rate. 
 
Predictor      df   F   p 
 
Target Group      41 .48 .75 
Country of Origin     41 .87 .49 
Publication Year     24 .44 .97 
Psychotherapy vs. Control    44 .51 .48 
Psychotherapy vs  Medication   44 1.22 .28 
Psychotherapy vs. Combined treatment  44 2.57 .12 
Medication vs. Combined treatment   44 .27 .61 
Combined vs. Psychotherapy + Placebo  44 .06 .81 
Psychotherapy vs Psychotherapy   44 .40 .53 
Overall study size     5 .49 .91 
Studies involving Cognitive therapy   44 1.75 .19 
Studies involving Interpersonal therapy  44 1.14 .29 
Studies involving Problem-Solving therapy  44 .45 .51 
Studies involving Supportive-Expressive therapy 44 1.43 .24 
Studies involving Behavioral therapy   44 0 .99 
Studies involving Psychodynamic therapy  44 .28 .60 
Studies involving “other” therapies   44 .04 .84 
 
Variables reported above were available for all 46 studies included in the meta-analysis. 
Individual studies could be categorized into multiple treatment type and comparison type 
variables.  
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Figure 1. Flow diagram of study collection process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
243 articles downloaded per database 
from psychotherapyrcts.org (as of 07/10) 
113 articles meet preliminary inclusion 
criteria; enter detailed review process 
46 articles satisfy all inclusion criteria 
and are included in meta-analysis 
130 articles removed for failure to 
involve (a) individual therapy 
and/or (b) formal diagnostic 
assessment of depression 
67 articles excluded due to: 
- depression diagnostic issue (29) 
- insufficient dropout info (18) 
- not solely individual therapy (6) 
- non-English publication (5) 
- could not separate dropout from    
  administrative removal (4) 
- could not determine study N (2) 
- therapy not face-to-face (1) 
- not acute treatment phase (1) 
- duplicate dataset (1) 
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Figure 2. Forest plot of treatment-level dropout rate.  
 
 
The figure above depicts dropout rates, with 95% confidence intervals, for each condition 
included in the primary analysis. The vertical line denotes the group mean dropout rate 
(approximately 17%). Labels on the vertical axis include treatment number (as per Appendix 2), 
name of the first author, year of publication, and treatment type of the condition. Note that 
because all values represent probabilities, low dropout rates with wide confidence intervals are in 
some cases necessarily bounded on one side by zero.  
  
Percentage Dropout 
10. Constantino(2008)-CBT 
45. Murphy(1984)-CBT 
46. Murphy(1995)-CBT 
68. Wiles(2008)-CBT 
58. Sloane(1985)-IPT 
1. Alexopoulos(2003)-PST   
2. Alexopoulos(2003)-SUP   
36. Lesperance(2007)-IPT    
47. Mynors-Wallis(1995)-PST 
31. Jacobson(1996)-CBT 
40. McKnight(1992)-CBT    
11. Cooper(2003)-CBT 
35. Laidlaw(2008)-CBT    
42. Mohr(2001)-CBT 
54. Rush(1977)-CBT 
14. David(2008)-CBT 
29. Jacobson(1996)-CBT 
15. David(2008)-CBT 
25. Gallagher(1982)-CBT 
39. Macaskil(1996)-CBT    
16. De Jonghe(2001)-DYN 
41. Misri(2004)-CBT    
30. Jacobson(1996)-BAT 
6. Burnand(2002)-DYN   
5. Blackburn(1997)-CBT   
23. Dozois(2009)-CBT    
37. Lesperance(2007)-IPT    
60. Teasdale(1984)-CBT    
12. Cooper(2003)-SUP 
22. Dimidjian(2006)-CBT 
69. Wright(2005)-CBT 
32. Jarrett(1999)-CBT    
7. Castonguay(2004)-OTH   
20. DeRubeis(2005)-CBT    
55. Salminen(2008)-DYN    
66. Van Schaik(2006)-IPT    
63. Thompson(1987)-BAT 
21. Dimidjian(2006)-BAT 
53. Padfield(1976)-PST 
62. Thompson(1987)-DYN 
50. Mynors-Wallis(2000)-PST 
44. Murphy(1984)-CBT 
59. Swartz(2008)-IPT    
38. Lustman(1998)-CBT    
51. O'Hara(2000)-IPT    
13. Cooper(2003)-DYN 
43. Murphy(1984)-CBT 
34. Keller(2000)-OTH    
49. Mynors-Wallis(2000)-PST 
3. Beck(1985)-CBT   
64. Thompson(2001)-CBT 
8.* Conradi(2007)-CBT   
57. Scott(1997)-CBT 
4. Beck(1985)-CBT   
9. Constantino(2008)-CBT 
17. De Jonghe(2004)-DYN 
33. Keller(2000)-OTH    
18. De Jonghe(2004)-DYN 
26. Gallagher(1982)-DYN 
67. Vitriol(2009)-IPT    
65. Thompson(2001)-CBT 
52. Padfield(1976)-SUP 
48. Mynors-Wallis(2000)-PST 
27. Hollon(1992)-CBT    
28. Hollon(1992)-CBT    
61. Thompson(1987)-CBT 
56. Schulberg(1996)-IPT    
19. Dekker(2008)-DYN    
24. Gallagher(1982)-BAT  
 
40 
 
Figure 3. Forest plot of study-level dropout rates.  
 
 
The figure above depicts untransformed dropout rates, with 95% confidence intervals, for each 
study included in the secondary analysis. The vertical line denotes the group mean dropout rate 
(approximately 19%). Labels on the vertical axis include study number, name of the first author 
and year of publication. Note that because all values represent probabilities, low dropout rates 
with wide confidence intervals are in some cases necessarily bounded on one side by zero.  
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30. Mynors-Wallis (1995) 
41. Thompson (1987) 
 3. Blackburn (1997)   
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39. Swartz (2008)   
29. Murphy (1995) 
40. Teasdale (1984)   
10. De Jonghe (2001) 
31. Mynors-Wallis (2000) 
 2. Beck (1985)   
33. Padfield (1976) 
19. Jarrett (1999)   
20. Keller (2000)   
28. Murphy (1984) 
16. Gallagher (1982) 
11. De Jonghe (2004) 
37. Scott (1997) 
14. Dimidjian (2006) 
17. Hollon (1992)   
32. O'Hara (2000)   
36. Schulberg (1996)   
43. Vitriol (2009) 
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Figure 4. Funnel plot of standard error of dropout estimate by dropout rate.  
 
 
 
 
The figure above features the standard error of the dropout estimate, plotted against the dropout 
rate, for all 46 studies included in this meta-analysis (per Sterne & Harbord, 2004).  
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Appendix 1 
 
*Note: Studies are identified by first author and date of publication. Complete citations can be 
found in at psychotherapyrcts.org. 
 
Removed due to inability to distinguish dropout from withdrawal by study personnel 
 
Bellack, 1981 Bellino, 2006 Elkin, 1990 Weissman, 1979 
 
Removed due to depression diagnostic issue (e.g., no formal assessment; primary dysthymia) 
 
Appleby, 1997 
Barrett, 2001 
Beutler, 2003 
Brown, 1984 
Browne, 2002 
Carpenter, 2008 
Cho, 2008 
De Mello, 2001 
Dowrick, 2000 
Dunner, 1996 
Floyd, 2004 
Freedland, 2009 
Gallagher, 1994 
Hernandez, 2004 
Holden, 1989 
Maina, 2005 
Markowitz, 2005 
Markowitz, 2008 
McGrath, 1996 
Prendergast, 2001 
Safran, 2009 
Selmi, 1990 
Serfaty, 2009 
Strauman, 2006 
Teichmann, 1995 
Teri, 1986 
Teri, 1997 
Wierzbicki, 1987 
Williams, 2000 
 
Removed because information on dropout / treatment-level dropout could not be identified 
 
Alladin, 2007 
Bedi, 2000 
Blom, 2007 
Carrington, 1979 
Martin, 2001 
Marshall, 2008 
McBride, 2007 
Pecheur, 1980 
Reynolds, 1999 
Ross, 1985 
Schiffer, 1990 
Schmitz, 2001 
Scoot, 1992 
Shamsei, 2008 
Sirey, 2005 
Spinelliy, 2003 
Thompson, 1984 
Wickberg, 1996 
 
Removed because paper was not published in English 
 
Hautzinger, 1996 
Krampen, 1997 
Lopez, 2004 Maldonado-
Lopez, 1982 
Maldonado-
Lopez, 1984 
 
Removed because treatment was not exclusively individual / one-to-one (e.g. couples) 
 
Beach, 1992 
Bodenmann, 2008 
Leff, 2000 
McLean, 1979 
Milgrom, 2005 
Scott, 1990 
 
Removed for other reasons  
 
Chaput, 2008 – not acute treatment phase 
Ransom, 2008 – intervention not always  delivered face-to-face 
Banken, 1993 – could not identify critical study data (i.e., study N) 
Cullen, 2002 – could not identify critical study data (i.e., study N)
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Appendix 2 
 
Study     ID # Condition Descriptor         Study        ID #     Condition Descriptor
Alexopolous, 2003  1 Problem-solving  
Alexopolous, 2003 2 Supportive 
Beck, 1985  3 CT 
Beck, 1985  4 CT + amitryptiline 
Blackburn, 1997  5 CT 
Burnand, 2002  6 Dynamic + clomipramine 
Castonguay, 2004 7 Integrative CT 
Conradi, 2007*  8 Brief CT + DRPP 
Constantino, 2008 9 CT 
Constantino, 2008 10 Integrative CT 
Cooper, 2003  11 CT 
Cooper, 2003  12 Non-directive counseling 
Cooper, 2003  13 Dynamic 
David, 2008  14 REBT 
David, 2008  15 CT 
De Jonghe, 2001  16 Analytic + ADM 
De Jonghe, 2004  17 Supportive Dynamic 
De Jonghe, 2004  18 Supportive Dynamic + ADM 
Dekker, 2008  19 Brief Dynamic 
DeRubeis, 2005  20 CT 
Dimidjian, 2006  21 Behavioral 
Dimidjian, 2006  22 CT 
Dozois, 2009  23 CT + ADM 
Gallagher, 1982  24 Behavioral 
Gallagher, 1982  25 CT 
Gallagher, 1982  26 Insight-oriented 
Hollon, 1992  27 CT 
Hollon, 1992  28 CT + imipramine 
Jacobson, 1996  29 Behavioral + AT 
Jacobson, 1996  30 Behavioral 
Jacobson, 1996  31 CT 
Jarrett, 1999  32 CT 
Keller, 2000  33 CBASP 
Keller, 2000  34 CBASP + nefazodone 
Laidlaw, 2008  35 CT 
Lesperance, 2007  36 Interpersonal + citalopram 
Lesperance, 2007  37 Interpersonal + placebo 
Lustman, 1998  38 CT 
Macaskil, 1996  39 RET + lofepramine 
McKnight, 1992  40 CT 
Misri, 2004  41 CT + paroxetine 
Mohr, 2001  42 CT 
Murphy, 1984  43 CT 
Murphy, 1984  44 CT + ADM 
Murphy, 1984  45 CT + placebo 
Murphy, 1995  46 CT 
Mynors-Wallis, 1995 47 Problem-solving 
Mynors-Wallis, 2000 48 Problem-solving (GP) 
Mynors-Wallis, 2000 49 Problem-solving (RN) 
Mynors-Wallis, 2000 50 Problem-solving + ADM 
O’Hara, 2000  51 Interpersonal 
Padfield, 1976  52 Positive reinforcement 
Padfield, 1976  53 Behavioral 
Rush, 1977  54 CT 
Salminen, 2008  55 Interpersonal 
Schulberg, 1996  56 Interpersonal 
Scott, 1997  57  Brief CT + TAU 
Sloane, 1985  58 Interpersonal 
Swartz, 2008  59 IPT-MOMS 
Teasdale, 1984  60 CT + TAU 
Thompson, 1987  61 CT 
Thompson, 1987  62 Brief dynamic 
Thompson, 1987  63 Behavioral 
Thompson, 2001  64 CT 
Thompson, 2001  65 CT + desipramine 
Van Schaik, 2006 66 Interpersonal 
Vitriol, 2009  67 Brief IPT 
Wiles, 2008  68 CT 
Wright, 2005  69 CT 
